Contact Pol

Speaking Engagements

  

Global Engage is pleased to announce the 5th Global NASH Congress, which will be taking place on the 14th and 15th of March 2022 in London. An increasing number of people are being diagnosed with nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH) each year, and the primary method of treatment is weight loss.

26-27 May 2022
  

Discovery on Target (DOT) highlights advances in current and emerging “hot” targets and technologies, as well as target validation strategies for the discovery and development of novel therapeutic agents ranging from biologics to small molecules. We aim to meet your research needs.

17-20 October 2022
  

Cambridge Healthtech Institute’s two-part conference on Artificial Intelligence (AI)/Machine Learning (ML)-Enabled Drug Discovery will highlight the increasing use of computational tools, AI modeling, algorithms, and data science for identifying novel drug targets, drug design, virtual screening, lead optimization, and ADME/toxicology assessments.

26-27 September 2023
  

Fibrosis can be viewed as the end-stage of chronic inflammation. Fibrosis and inflammation are related to the immune system gone awry and both underlie many conditions related to aging and therefore are increasing in prevalence in the US. Cambridge Healthtech Institute's Fibrosis and Inflammation conference continues its fifth year of focusing in t

27-28 September 2023